BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
This study has been completed.
First Posted: June 4, 2004
Last Update Posted: January 30, 2017
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||October 2002|
|Primary Completion Date:||October 2002 (Final data collection date for primary outcome measure)|
Aghajanian C, Burris HA 3rd, Jones S, Spriggs DR, Cohen MB, Peck R, Sabbatini P, Hensley ML, Greco FA, Dupont J, O'Connor OA. Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas. J Clin Oncol. 2007 Mar 20;25(9):1082-8. Epub 2007 Jan 29.